Literature DB >> 1993303

Preferential involvement of 11q23-24 and 11p15 in breast cancer.

A Ferti-Passantonopoulou1, A D Panani, S Raptis.   

Abstract

Thirty cases of breast cancer were cytogenetically studied by G-banding using direct tumor preparations. Among them 20 cases exhibited abnormalities of the long and/or short arm of chromosome 11. Thus, 11q was involved in 16 cases and 11p in ten cases. There was consistent involvement of bands 11q23-24 (15 cases) and 11p15 (9 cases), where the cellular oncogenes ets and H-ras 1, respectively, are located. These findings suggest that involvement of bands 11q23-24 and 11p15 may be specific in a group of breast cancers, leading to the activation of cellular oncogenes or loss of cancer suppressor genes.

Entities:  

Mesh:

Year:  1991        PMID: 1993303     DOI: 10.1016/0165-4608(91)90130-m

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

1.  Frequent loss of the BLID gene in early-onset breast cancer.

Authors:  L R Cavalli; A-M Noone; K H Makambi; J D Rone; U N Kasid; B R Haddad
Journal:  Cytogenet Genome Res       Date:  2011-08-12       Impact factor: 1.636

2.  Predisposition for breast cancer in carriers of constitutional translocation 11q;22q.

Authors:  A Lindblom; K Sandelin; L Iselius; J Dumanski; I White; M Nordenskjöld; C Larsson
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

3.  Chromosomal instability in breast cancer patients.

Authors:  L Barrios; M R Caballín; R Miró; C Fuster; F Guedea; A Subias; J Egozcue
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

4.  Loss of heterozygosity on chromosome 11 q in breast cancer.

Authors:  I P Tomlinson; J E Strickland; A S Lee; L Bromley; M F Evans; J Morton; J O McGee
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

5.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations.

Authors:  J Gudmundsson; R B Barkardottir; G Eiriksdottir; T Baldursson; A Arason; V Egilsson; S Ingvarsson
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.